Web Analytics

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella



Researchers aim to discover dominant subtypes of plasmablasts initiating from the MMR vaccine in order to develop neutralizing antibody candidate therapies



Summary

Researchers are investigating the plasmablast response triggered by the MMR (measles, mumps, and rubella) vaccine. Their goal is to identify the most prevalent and potent subtypes of plasmablasts generated post-vaccination. By understanding these dominant subtypes, they hope to isolate and characterize the antibodies they produce. Ultimately, this research aims to develop neutralizing antibody-based therapies against measles, mumps, and/or rubella. This could potentially lead to improved treatments and preventative measures against these diseases.

Read more…

This post is part of “Science and Technology News”, Follow for more…!!!

Credits: Source

Disclaimer


Discover more from abdullahfarhan.com

Subscribe to get the latest posts sent to your email.

Dr AF Saeed

Related post

Thank you for Visiting. Leave a Reply!

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.